Clinical Trial

Gotistobart Long Term Extension (LTE) Study

Name: Gotistobart Long Term Extension (LTE) Study — clinical trial record (NCT07659379)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This LTE study will examine the long-term overall survival and safety of gotistobart in patients with advanced solid tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-15.

Trial Details

NCT Number	NCT07659379
Lead Sponsor	OncoC4, Inc.
Conditions	Advanced Solid Tumor
Enrollment	20 participants
Start Date	2026-07-01
Primary Completion	2036-07-01 (estimated)
Study Completion	2037-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-23